Sean Carrick - 09 Mar 2022 Form 4 Insider Report for Nascent Biotech Inc.

Role
President & CEO, Director, 10%+ Owner
Signature
/s/ Sean Carrick
Issuer symbol
NBIO on OTC
Transactions as of
09 Mar 2022
Net transactions value
+$74,080
Form type
4
Filing time
04 Apr 2022, 16:01:15 UTC
Previous filing
20 Aug 2021
Next filing
03 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBIO Common Stock Other $50,000 +1,000,000 +6.2% $0.0500* 17,021,131 09 Mar 2022 Direct F1
transaction NBIO Common Stock Other $24,080 +430,000 +2.5% $0.0560* 17,451,131 31 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as part of the employment contract with the Company.